SCHEMBL16428433

SCHEMBL16428433

COc1cc2c(cc1OC)NC[C@H](N)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
DRD2 P14416 2/20 0.41
DRD3 P35462 2/20 0.41
ADRA1A P35348 1/20 0.39
EP300 Q09472 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
ACHE P22303 1/20 0.37
ALDH1A1 P00352 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
TSHR P16473 1/20 0.36
MAOA P21397 1/20 0.36
PDE4A P27815 3/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10809737 1.00 CYP3A4 (0.41) CYP3A4MAPTDRD2DRD3ADRA1A
Hydrochloric Acid SCHEMBL10808561 0.98 DRD2 (0.40) CYP3A4MAPTDRD2DRD3ADRA1A
SCHEMBL16428194 0.79 EP300 (0.42) CYP3A4MAPTEP300CA1CA2
SCHEMBL16428197 0.79 EP300 (0.42) CYP3A4MAPTEP300CA1CA2
SCHEMBL3041826 0.77 ADRA1A (0.56) CYP3A4MAPTDRD2DRD3ADRA1A
SCHEMBL10809253 0.77 ALDH1A1 (0.44) CYP3A4MAPTDRD2DRD3EP300
Hydrochloric Acid SCHEMBL10813428 0.76 DRD2 (0.53) DRD2DRD3CA2ALDH1A1
Hydrochloric Acid SCHEMBL10815321 0.76 DRD2 (0.53) DRD2DRD3ACHE
Hydrochloric Acid SCHEMBL10808479 0.76 ALDH1A1 (0.43) CYP3A4MAPTDRD2DRD3EP300
Hydrochloric Acid SCHEMBL1788805 0.75 ADRA1A (0.54) CYP3A4MAPTDRD2DRD3ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9163038-B2 Process for synthesis of chiral 3-substituted tetrahydroquinoline derivatives COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-10-20 US disclosed
US-20150038714-A1 Process for Synthesis of Chiral 3-Substituted Tetrahydroquinoline Derivatives COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150038714-A1 Process for Synthesis of Chiral 3-Substituted Tetrahydroquinoline Derivatives TH, DHPS, QDPR CYP3A4 107/4885MAPT 3402/4885DRD2 266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.